InvestorsHub Logo

Det_Robert_Thorne

04/25/20 2:15 PM

#4632 RE: Randylus #4622

The 2019 10-K probably won't have PCTI financials.

The EOY 2019 10Q is officially due in three weeks as the company was granted relief under the special coronavirus grace period afforded all reporting companies. Some estimates are in the neighborhood of 12-14 million annual sales for PCTI, the target company.


Ozop's 2019 10-K will be covering OZSC's audited financials for the fiscal year that ended well before the RM (reverse merger) with PCTI was announced, so it's doubtful that they will include a detailed look into PCTI's financials.

There might be some language about the announcement of the RM in the Subsequent Events section.

The 10-Q covering 1Q/20 is due on May 15, but it will likely also be delayed due to the coronavirus. That report won't be required to disclose PCTI's numbers, because the merger wasn't closed during the time period of the report.

There will probably be an 8-K disclosing more of the terms and possibly PCTI's financials closer to the closing of the deal, which according to the Feb 28, 2020 8-K, should be towards the end of June.

When and if the deal is closed, I expect that the fully-diluted OS will be somewhere between 500M and 700M shares, based on the current OS of 35M - 60M shares (we'll know the extent of the April dilution by May 5, or so), plus the debt for equity shares as part of the deal with the OZSC debtholders, multiplied by 3 to account for the eventual conversion of the Series D preferred stock that will be held by PCTI CEO Catherine Chis.